PDT Partners’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-15,009
| Closed | -$102K | – | 955 |
|
|
2021
Q2 | $102K | Buy |
15,009
+2,674
| +22% | +$18.2K | 0.01% | 763 |
|
|
2021
Q1 | $127K | Buy |
+12,335
| New | +$127K | 0.01% | 728 |
|
|
2020
Q2 | – | Sell |
-61,968
| Closed | -$294K | – | 865 |
|
|
2020
Q1 | $294K | Buy |
61,968
+48,700
| +367% | +$231K | 0.02% | 481 |
|
|
2019
Q4 | $116K | Sell |
13,268
-13,632
| -51% | -$119K | 0.01% | 684 |
|
|
2019
Q3 | $90K | Sell |
26,900
-3,800
| -12% | -$12.7K | 0.01% | 439 |
|
|
2019
Q2 | $152K | Sell |
30,700
-12,412
| -29% | -$61.5K | 0.01% | 388 |
|
|
2019
Q1 | $267K | Buy |
+43,112
| New | +$267K | 0.02% | 366 |
|